Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Radiotherapy breakthrough: Oscar Lambret Center celebrates world first

20 Aug 2013 | A region on the move, Health Nutrition

Lille's Oscar Lambret Center, a standard-setter in cancer treatment, offers increasingly innovative and targeted therapies

Oscar-Lambret - TomoTherapy - Radiotherapy - hospital - cancer - Lille Region

In 2012, the Oscar Lambret Center acquired its third TomoTherapy platform—a new TomoHDA™ that harnesses imaging technology to deliver intensity-modulated radiation therapy (IMRT). Oncologists and radiation therapists at the center can now "use 3-dimensional images to administer ultra-targeted radiation treatments," says Dr. Éric Lartigau, Director of Research and Cooperation at the center.

The primary benefits of this innovative technology are spectacular improvement in patients’ radiation tolerance and integrated radiation scheduling and delivery. "This is the best possible treatment scenario,” says Dr. Lartigau. “We can administer high-dose radiation to the tumor while protecting healthy organs.” And there’s an additional benefit for patients: "treatments are better tolerated¬—each session is shorter, too—and there are fewer side effects, so we can complete full cycles with no interruptions. That's a critical advantage for effective treatment," notes Lartigau.

The breakthrough was the product of an ongoing partnership launched six years ago between teams at the Oscar Lambret Center and at Accuray, a global leader in radiotherapy and manufacturer of the TomoHDA™. The world’s first treatments with the unit were administered on April 23 this year and have proven completely safe. To date it has improved the lives of 70 patients.

Source: Unicancer, La Voix du nord

Back to news

News

Häagen-Dazs launches mini-bars

Häagen-Dazs is set to invest €14 billion to produce mini ice cream bars at its plant in Hauts-de-France, near Arras.

Prysmian Draka Filéca invests in Beauvais plant

The world leader in energy and telecom cables is investing €7 million at its site in Hauts-de-France to shift production of key raw materials in-house.

All news